298 related articles for article (PubMed ID: 20031718)
21. Stent thrombosis with drug-eluting stents: a re-examination of the evidence.
Kedia G; Lee MS
Catheter Cardiovasc Interv; 2007 May; 69(6):782-9. PubMed ID: 17394249
[TBL] [Abstract][Full Text] [Related]
22. Long-term paclitaxel-eluting stent outcomes in elderly patients.
Forman DE; Cox DA; Ellis SG; Lasala JM; Ormiston JA; Stone GW; Turco MA; Wei JY; Joshi AA; Dawkins KD; Baim DS
Circ Cardiovasc Interv; 2009 Jun; 2(3):178-87. PubMed ID: 20031714
[TBL] [Abstract][Full Text] [Related]
23. Timing of noncardiac surgery after coronary artery stenting with bare metal or drug-eluting stents.
van Kuijk JP; Flu WJ; Schouten O; Hoeks SE; Schenkeveld L; de Jaegere PP; Bax JJ; van Domburg RT; Serruys PW; Poldermans D
Am J Cardiol; 2009 Nov; 104(9):1229-34. PubMed ID: 19840567
[TBL] [Abstract][Full Text] [Related]
24. Incidence, predictors, and prognostic implications of hospitalization for late bleeding after percutaneous coronary intervention for patients older than 65 years.
Ko DT; Yun L; Wijeysundera HC; Jackevicius CA; Rao SV; Austin PC; Marquis JF; Tu JV
Circ Cardiovasc Interv; 2010 Apr; 3(2):140-7. PubMed ID: 20332382
[TBL] [Abstract][Full Text] [Related]
25. Effect of length and diameter of drug-eluting stents versus bare-metal stents on late outcomes.
Applegate RJ; Sacrinty MT; Kutcher MA; Santos RM; Gandhi SK; Little WC
Circ Cardiovasc Interv; 2009 Feb; 2(1):35-42. PubMed ID: 20031691
[TBL] [Abstract][Full Text] [Related]
26. Outcomes after percutaneous coronary intervention of ostial lesions in the era of drug-eluting stents.
Freeman M; Clark DJ; Andrianopoulos N; Duffy SJ; Lim HS; Brennan A; Charter K; Shaw J; Horrigan M; Ajani AE; Sebastian M; Reid CM; Farouque HM;
Catheter Cardiovasc Interv; 2009 May; 73(6):763-8. PubMed ID: 19309731
[TBL] [Abstract][Full Text] [Related]
27. Drug-eluting stent thrombosis.
Stähli BE; Camici GG; Tanner FC
Ther Adv Cardiovasc Dis; 2009 Feb; 3(1):45-52. PubMed ID: 19124388
[TBL] [Abstract][Full Text] [Related]
28. Evidence-based management of patients undergoing PCI: stent controversies.
Vetrovec GW
Catheter Cardiovasc Interv; 2010 Mar; 75 Suppl 1():S39-42. PubMed ID: 20333706
[TBL] [Abstract][Full Text] [Related]
29. Late outcomes after drug-eluting stent implantation in "real-world" clinical practice.
Ramsdale DR; Rao A; Asghar O; Ramsdale KA; McKay E
J Invasive Cardiol; 2008 Oct; 20(10):493-500. PubMed ID: 18829991
[TBL] [Abstract][Full Text] [Related]
30. Long-term outcome of patients of over 85 years old with acute coronary syndrome undergoing percutaneous coronary stenting: a comparison of bare metal stent and drug eluting stent.
Ma HY; Zhou YJ; Dick RJ; Shi DM; Liu YY; Cheng WJ; Guo YH; Wang JL; Ge HL
Chin Med J (Engl); 2008 May; 121(10):887-91. PubMed ID: 18706201
[TBL] [Abstract][Full Text] [Related]
31. Long-term clinical outcomes of real-world experience using sirolimus-eluting stents in saphenous vein graft disease.
Ramana RK; Ronan A; Cohoon K; Homan D; Sutherland J; Steen L; Liu J; Loeb H; Lewis BE
Catheter Cardiovasc Interv; 2008 Jun; 71(7):886-93. PubMed ID: 18412238
[TBL] [Abstract][Full Text] [Related]
32. Risk of major bleeding with concomitant dual antiplatelet therapy after percutaneous coronary intervention in patients receiving long-term warfarin therapy.
DeEugenio D; Kolman L; DeCaro M; Andrel J; Chervoneva I; Duong P; Lam L; McGowan C; Lee G; DeCaro M; Ruggiero N; Singhal S; Greenspon A
Pharmacotherapy; 2007 May; 27(5):691-6. PubMed ID: 17461704
[TBL] [Abstract][Full Text] [Related]
33. Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation implications for bleeding risk and prognosis.
Ruiz-Nodar JM; Marín F; Hurtado JA; Valencia J; Pinar E; Pineda J; Gimeno JR; Sogorb F; Valdés M; Lip GY
J Am Coll Cardiol; 2008 Feb; 51(8):818-25. PubMed ID: 18294566
[TBL] [Abstract][Full Text] [Related]
34. Aspirin desensitization in patients undergoing percutaneous coronary interventions with stent implantation.
Rossini R; Angiolillo DJ; Musumeci G; Scuri P; Invernizzi P; Bass TA; Mihalcsik L; Gavazzi A
Am J Cardiol; 2008 Mar; 101(6):786-9. PubMed ID: 18328841
[TBL] [Abstract][Full Text] [Related]
35. Multivessel drug-eluting stenting and impact of diabetes mellitus--a report from the EVENT registry.
Novack V; Tsyvine D; Cohen DJ; Pencina M; Dubin J; Dehghani H; Kleiman NS; Cutlip DE
Catheter Cardiovasc Interv; 2009 Jun; 73(7):874-80. PubMed ID: 19180665
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and safety of drug-eluting stent use in patients with atrial fibrillation.
Ruiz-Nodar JM; Marín F; Sánchez-Payá J; Hurtado JA; Valencia-Martín J; Manzano-Fernández S; Roldán V; Pérez-Andreu V; Sogorb F; Valdés M; Lip GY
Eur Heart J; 2009 Apr; 30(8):932-9. PubMed ID: 19246502
[TBL] [Abstract][Full Text] [Related]
37. Incidence, predictors, and clinical impact of bleeding after transradial coronary stenting and maximal antiplatelet therapy.
Bertrand OF; Larose E; Rodés-Cabau J; Gleeton O; Taillon I; Roy L; Poirier P; Costerousse O; Larochellière RD
Am Heart J; 2009 Jan; 157(1):164-9. PubMed ID: 19081414
[TBL] [Abstract][Full Text] [Related]
38. Frequency and risk of noncardiac surgery after drug-eluting stent implantation.
Gandhi NK; Abdel-Karim AR; Banerjee S; Brilakis ES
Catheter Cardiovasc Interv; 2011 Jun; 77(7):972-6. PubMed ID: 20824750
[TBL] [Abstract][Full Text] [Related]
39. [Perioperative management and postoperative complication rates of patients on dual antiplatelet therapies after coronary drug eluting stent implantation].
Komiya R; Kamintani K; Kubo E; Hattori M; Kataoka H; Iwase Y; Miyoshi H; Minami M; Kato S; Arai R; Yoshida H
Masui; 2014 Jun; 63(6):629-35. PubMed ID: 24979851
[TBL] [Abstract][Full Text] [Related]
40. Dual antiplatelet therapy with aspirin and clopidogrel: what is the risk in noncardiac surgery? A narrative review.
Finkel JB; Marhefka GD; Weitz HH
Hosp Pract (1995); 2013 Feb; 41(1):79-88. PubMed ID: 23466970
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
